Theo M. De Witte

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes.

The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes.

Journal: EJHaem

Published: January 29, 2026

Estimating the Causal Effect of Realistic Treatment Strategies Using Longitudinal Observational Data.

Estimating the Causal Effect of Realistic Treatment Strategies Using Longitudinal Observational Data.

Journal: Medical decision making : an international journal of the Society for Medical Decision Making

Published: October 27, 2025

Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.

Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.

Journal: British journal of haematology

Published: September 03, 2025

Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry.

Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry.

Journal: Haematologica

Published: October 31, 2024

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT.

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT.

Journal: Blood

Published: October 21, 2024

Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.

Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.

Journal: HemaSphere

Published: August 30, 2024

Inflammatory profile of lower risk myelodysplastic syndromes.

Inflammatory profile of lower risk myelodysplastic syndromes.

Journal: British journal of haematology

Published: December 22, 2023

Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.

Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.

Journal: Blood

Published: December 06, 2023

Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial.

Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial.

Journal: American journal of hematology

Published: December 01, 2023

Oral decitabine plus cedazuridine versus intravenous decitabine.

Oral decitabine plus cedazuridine versus intravenous decitabine.

Journal: The Lancet. Haematology

Published: November 21, 2023

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.

Journal: Nature communications

Published: May 09, 2023

CPX-351 for higher risk myelodysplastic syndrome: cytarabine and daunorubicin in disguise?

CPX-351 for higher risk myelodysplastic syndrome: cytarabine and daunorubicin in disguise?

Journal: The Lancet. Haematology

Published: May 08, 2023

Showing 1-12 of 139

Last Updated: 09/26/2026